side effects of taking too much semaglutide FDA alerts health care providers, compounders and patients dosing errors associated with compounded injectable products Some people are overdosing on

They all outperform U.S

Individuals between 55 and 64 years of age were more frequently prescribed semaglutide than those who were between 18 and 24 years of age

The FDA specifically mentions their concern whether the impurities contain sequences that have an increased affinity for major histocompatibility complex (MHC), known as T-cell epitopes in their final guidance [1]

The real concern I have is the marketing

Clinical Monitoring and Provider Decision Framework If your provider determines GLP-1 therapy is appropriate despite pancreatitis history, baseline pancreatic imaging, lipase, and amylase are standard precautions

Possibly, but unlikely to the full extent